Sharps Technology enters exclusive U.S. distribution agreement with Nephron Pharmaceuticals for syringe products

Sharps Technology Inc.

Distribution agreement appoints Nephron as exclusive U.S. distributor for Sharps' syringe products.
First products expected available by end of January 2023; initial revenue anticipated in first half of 2023.
Agreement supports previously announced Inject-EZ startup in South Carolina, expected to begin in early 2023.
Two-year term, with 30-day termination notice by either party for any reason.
Nephron's sales network includes over 3,000 customers via direct and online channels.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Sharps Technology Inc. entered into Distribution Agreement with Nephron Pharmaceuticals Corporation and Nephron SC, Inc. (collectively, "Nephron") (effective 2022-12-08).

Action: entry
Agreement: supply
Counterparty: Nephron Pharmaceuticals Corporation and Nephron SC, Inc. (collectively, "Nephron")
Effective: 2022-12-08

Exact text from the filing

On December 8, 2022, Sharps Technology, Inc. (the “Company”) entered into a distribution agreement (the “Distribution Agreement”) with Nephron Pharmaceuticals Corporation and Nephron SC, Inc. (collectively, “Nephron”), pursuant to which the Company appointed Nephron as its exclusive distributor for the sale and distribution of the products subject to the Distribution Agreement in and throughout the United States.

View on SEC.gov

119 material agreements filed in the last 30 days. Browse all material agreements →

Sharps Technology Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-035248

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.